Christopher Peetz - Feb 2, 2024 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Feb 2, 2024
Transactions value $
-$157,491
Form type
4
Date filed
2/5/2024, 09:04 PM
Previous filing
Jan 25, 2024
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale -$157K -6.01K -5.46% $26.19 104K Feb 2, 2024 Direct F1
holding MIRM Common Stock 202K Feb 2, 2024 By The Peetz Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.